Will Aurion Biotech’s IPO Survive a Legal Storm? Discover the Eye-Catching Details
Aurion Biotech plans to IPO on the New York Stock Exchange under the ticker "AURN." Challenges include a lawsuit from Alcon Research alleging violations of shareholder rights. Aurion countersued, accusing…